跳至主要内容
临床试验/ACTRN12608000211369
ACTRN12608000211369已完成3 期

A randomised double blind placebo controlled trial of infusional subcutaneous octreotide in the management of malignant bowel obstruction in people with advanced cancer.

Flinders University0 个研究点目标入组 94 人开始时间: 2008年4月18日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • age >18 years
  • advanced cancer
  • disease-modifying therapy (chemotherapy, radiotherapy, hormone therapy, biological/targeted therapies) is deemed by relevant practitioners unlikely to change the bowel obstruction or the course of cancer.
  • presents with clinically confirmed bowel obstruction at any level and vomiting that precipitates a hospital admission or change in clinical care for those already in-patients
  • deemed by two consultant level medical practitioners that this person has a bowel obstruction (partial or complete) for which immediate surgery is not indicated
  • participant is capable of completing assessments and complying with the study procedures
  • participant is able to give fully informed written consent
  • Mini Mental State of >23
  • Not currently on octreotide

排除标准

  • previous adverse reaction to any of the study medications
  • Australian-modified Karnofsky performance score less than 30 at the beginning of the study
  • participants who have participated in a clinical study of a new chemical entity within the month prior to study entry.
  • calculated creatinine clearance <10ml/min
  • documented cirrhosis
  • venting or feeding gastrostomy or jejunostomy

研究者

相似试验